The polymorphisms of FGFR2 and MGAT5 affect the susceptibility to COPD in the Chinese people.
BMC Pulm Med
; 21(1): 129, 2021 Apr 20.
Article
em En
| MEDLINE
| ID: mdl-33879098
ABSTRACT
BACKGROUND:
Chronic obstructive pulmonary disease (COPD) is characterized by incomplete reversible airflow limitation and chronic inflammatory response lesions. This study mainly explored whether FGFR2 and MGAT5 polymorphisms affected the risk of COPD in the Chinese people.METHODS:
Five variants in FGFR2 and MGAT5 were chosen and genotyped using Agena MassARRAY platform from 315 COPD patients and 314 healthy controls. The correlation of FGFR2 and MGAT5 with COPD susceptibility was evaluated with odds ratio (OR) and 95% confidence interval (CI) via logistic regression.RESULTS:
We found rs2420915 enhanced the risk of COPD, while rs6430491, rs2593704 reduced the susceptibility of COPD (p < 0.05). Rs2420915 could promote the incidence of COPD in the elderly and nonsmokers. Rs1907240 and rs2257129 also increased the susceptibility to COPD in nonsmokers (p < 0.05). MGAT5-rs2593704 played a protective role in COPD development in different subgroups (age ≤ 70, male, smokers, and individuals with BMI ≤ 24 kg/m2). Meanwhile, rs6430491 was linked with a lower risk of COPD in nonsmoking and BMI ≤ 24 kg/m2 subgroups.CONCLUSIONS:
We concluded that FGFR2 and MGAT5 genetic polymorphisms are correlated with the risk of COPD in the Chinese people. These data underscored the important role of FGFR2 and MGAT5 gene in the occurrence of COPD and provided new biomarkers for COPD treatment. TRIAL REGISTRATION NA.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
N-Acetilglucosaminiltransferases
/
Polimorfismo de Nucleotídeo Único
/
Doença Pulmonar Obstrutiva Crônica
/
Receptor Tipo 2 de Fator de Crescimento de Fibroblastos
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article